nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—asthma—chronic obstructive pulmonary disease	0.766	1	CtDrD
Tiotropium—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0261	0.227	CbGbCtD
Tiotropium—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0261	0.227	CbGbCtD
Tiotropium—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0219	0.19	CbGbCtD
Tiotropium—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0141	0.123	CbGbCtD
Tiotropium—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0126	0.109	CbGbCtD
Tiotropium—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00739	0.0641	CbGbCtD
Tiotropium—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00698	0.0605	CbGbCtD
Tiotropium—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.000275	0.00259	CcSEcCtD
Tiotropium—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000272	0.00256	CcSEcCtD
Tiotropium—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.00256	CcSEcCtD
Tiotropium—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.000272	0.00256	CcSEcCtD
Tiotropium—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000271	0.00255	CcSEcCtD
Tiotropium—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.00255	CcSEcCtD
Tiotropium—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.00027	0.00255	CcSEcCtD
Tiotropium—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.00027	0.00254	CcSEcCtD
Tiotropium—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.00027	0.00254	CcSEcCtD
Tiotropium—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.00254	CcSEcCtD
Tiotropium—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.000269	0.00254	CcSEcCtD
Tiotropium—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.000269	0.00254	CcSEcCtD
Tiotropium—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000269	0.00253	CcSEcCtD
Tiotropium—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000269	0.00253	CcSEcCtD
Tiotropium—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000266	0.00251	CcSEcCtD
Tiotropium—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000265	0.0025	CcSEcCtD
Tiotropium—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000264	0.00249	CcSEcCtD
Tiotropium—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.00249	CcSEcCtD
Tiotropium—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.000264	0.00249	CcSEcCtD
Tiotropium—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000263	0.00248	CcSEcCtD
Tiotropium—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00245	CcSEcCtD
Tiotropium—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.00242	CcSEcCtD
Tiotropium—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00241	CcSEcCtD
Tiotropium—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.0024	CcSEcCtD
Tiotropium—Infection—Aminophylline—chronic obstructive pulmonary disease	0.000254	0.0024	CcSEcCtD
Tiotropium—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000254	0.00239	CcSEcCtD
Tiotropium—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00239	CcSEcCtD
Tiotropium—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000252	0.00237	CcSEcCtD
Tiotropium—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000251	0.00236	CcSEcCtD
Tiotropium—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00025	0.00235	CcSEcCtD
Tiotropium—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.00233	CcSEcCtD
Tiotropium—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000248	0.00233	CcSEcCtD
Tiotropium—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.00233	CcSEcCtD
Tiotropium—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000247	0.00233	CcSEcCtD
Tiotropium—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000245	0.00231	CcSEcCtD
Tiotropium—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000245	0.00231	CcSEcCtD
Tiotropium—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000244	0.0023	CcSEcCtD
Tiotropium—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00229	CcSEcCtD
Tiotropium—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00228	CcSEcCtD
Tiotropium—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000242	0.00228	CcSEcCtD
Tiotropium—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000242	0.00228	CcSEcCtD
Tiotropium—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00024	0.00227	CcSEcCtD
Tiotropium—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.00226	CcSEcCtD
Tiotropium—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00024	0.00226	CcSEcCtD
Tiotropium—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000239	0.00225	CcSEcCtD
Tiotropium—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000239	0.00225	CcSEcCtD
Tiotropium—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.000235	0.00222	CcSEcCtD
Tiotropium—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00221	CcSEcCtD
Tiotropium—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.0022	CcSEcCtD
Tiotropium—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.0022	CcSEcCtD
Tiotropium—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000231	0.00218	CcSEcCtD
Tiotropium—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000231	0.00218	CcSEcCtD
Tiotropium—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000231	0.00218	CcSEcCtD
Tiotropium—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000231	0.00218	CcSEcCtD
Tiotropium—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000228	0.00215	CcSEcCtD
Tiotropium—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.000227	0.00214	CcSEcCtD
Tiotropium—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00214	CcSEcCtD
Tiotropium—Cataract—Prednisone—chronic obstructive pulmonary disease	0.000226	0.00213	CcSEcCtD
Tiotropium—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00212	CcSEcCtD
Tiotropium—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000225	0.00212	CcSEcCtD
Tiotropium—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00205	CcSEcCtD
Tiotropium—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00205	CcSEcCtD
Tiotropium—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000218	0.00205	CcSEcCtD
Tiotropium—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000214	0.00201	CcSEcCtD
Tiotropium—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.00199	CcSEcCtD
Tiotropium—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000211	0.00199	CcSEcCtD
Tiotropium—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000209	0.00197	CcSEcCtD
Tiotropium—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.00196	CcSEcCtD
Tiotropium—Cough—Formoterol—chronic obstructive pulmonary disease	0.000208	0.00196	CcSEcCtD
Tiotropium—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00195	CcSEcCtD
Tiotropium—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.00194	CcSEcCtD
Tiotropium—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000206	0.00194	CcSEcCtD
Tiotropium—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.00194	CcSEcCtD
Tiotropium—Cough—Montelukast—chronic obstructive pulmonary disease	0.000204	0.00192	CcSEcCtD
Tiotropium—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000203	0.00192	CcSEcCtD
Tiotropium—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000203	0.00191	CcSEcCtD
Tiotropium—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000203	0.00191	CcSEcCtD
Tiotropium—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000203	0.00191	CcSEcCtD
Tiotropium—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.00191	CcSEcCtD
Tiotropium—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.00191	CcSEcCtD
Tiotropium—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.00191	CcSEcCtD
Tiotropium—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000202	0.00191	CcSEcCtD
Tiotropium—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.0019	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000202	0.0019	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000202	0.0019	CcSEcCtD
Tiotropium—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00188	CcSEcCtD
Tiotropium—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000199	0.00188	CcSEcCtD
Tiotropium—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000199	0.00188	CcSEcCtD
Tiotropium—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000199	0.00187	CcSEcCtD
Tiotropium—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.00187	CcSEcCtD
Tiotropium—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00187	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000198	0.00186	CcSEcCtD
Tiotropium—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.00185	CcSEcCtD
Tiotropium—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.00185	CcSEcCtD
Tiotropium—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000195	0.00184	CcSEcCtD
Tiotropium—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.00184	CcSEcCtD
Tiotropium—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00183	CcSEcCtD
Tiotropium—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000193	0.00182	CcSEcCtD
Tiotropium—Infection—Formoterol—chronic obstructive pulmonary disease	0.000193	0.00182	CcSEcCtD
Tiotropium—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00181	CcSEcCtD
Tiotropium—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00181	CcSEcCtD
Tiotropium—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00181	CcSEcCtD
Tiotropium—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.0018	CcSEcCtD
Tiotropium—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000191	0.0018	CcSEcCtD
Tiotropium—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000191	0.0018	CcSEcCtD
Tiotropium—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00019	0.00179	CcSEcCtD
Tiotropium—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00019	0.00179	CcSEcCtD
Tiotropium—Infection—Montelukast—chronic obstructive pulmonary disease	0.000189	0.00179	CcSEcCtD
Tiotropium—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000189	0.00178	CcSEcCtD
Tiotropium—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000189	0.00178	CcSEcCtD
Tiotropium—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000188	0.00178	CcSEcCtD
Tiotropium—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00177	CcSEcCtD
Tiotropium—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000187	0.00176	CcSEcCtD
Tiotropium—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000185	0.00175	CcSEcCtD
Tiotropium—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.00173	CcSEcCtD
Tiotropium—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000183	0.00172	CcSEcCtD
Tiotropium—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000181	0.00171	CcSEcCtD
Tiotropium—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.0017	CcSEcCtD
Tiotropium—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.0017	CcSEcCtD
Tiotropium—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00169	CcSEcCtD
Tiotropium—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00168	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000177	0.00167	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000177	0.00167	CcSEcCtD
Tiotropium—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000176	0.00166	CcSEcCtD
Tiotropium—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.00166	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000174	0.00164	CcSEcCtD
Tiotropium—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00163	CcSEcCtD
Tiotropium—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00162	CcSEcCtD
Tiotropium—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00162	CcSEcCtD
Tiotropium—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000171	0.00161	CcSEcCtD
Tiotropium—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000169	0.00159	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00158	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00158	CcSEcCtD
Tiotropium—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000168	0.00158	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.00158	CcSEcCtD
Tiotropium—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000166	0.00157	CcSEcCtD
Tiotropium—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000166	0.00157	CcSEcCtD
Tiotropium—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00157	CcSEcCtD
Tiotropium—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00156	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00155	CcSEcCtD
Tiotropium—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000163	0.00153	CcSEcCtD
Tiotropium—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00153	CcSEcCtD
Tiotropium—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000161	0.00152	CcSEcCtD
Tiotropium—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000161	0.00152	CcSEcCtD
Tiotropium—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00016	0.00151	CcSEcCtD
Tiotropium—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.0015	CcSEcCtD
Tiotropium—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000159	0.0015	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.0015	CcSEcCtD
Tiotropium—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000157	0.00148	CcSEcCtD
Tiotropium—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000156	0.00147	CcSEcCtD
Tiotropium—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00146	CcSEcCtD
Tiotropium—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00146	CcSEcCtD
Tiotropium—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00145	CcSEcCtD
Tiotropium—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00145	CcSEcCtD
Tiotropium—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000152	0.00143	CcSEcCtD
Tiotropium—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000151	0.00143	CcSEcCtD
Tiotropium—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000151	0.00142	CcSEcCtD
Tiotropium—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00142	CcSEcCtD
Tiotropium—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00138	CcSEcCtD
Tiotropium—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00137	CcSEcCtD
Tiotropium—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000143	0.00135	CcSEcCtD
Tiotropium—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000143	0.00135	CcSEcCtD
Tiotropium—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.00135	CcSEcCtD
Tiotropium—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00135	CcSEcCtD
Tiotropium—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00014	0.00132	CcSEcCtD
Tiotropium—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.0013	CcSEcCtD
Tiotropium—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000138	0.0013	CcSEcCtD
Tiotropium—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000135	0.00128	CcSEcCtD
Tiotropium—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000135	0.00127	CcSEcCtD
Tiotropium—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.00125	CcSEcCtD
Tiotropium—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.00123	CcSEcCtD
Tiotropium—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00121	CcSEcCtD
Tiotropium—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00121	CcSEcCtD
Tiotropium—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00119	CcSEcCtD
Tiotropium—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000124	0.00117	CcSEcCtD
Tiotropium—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000124	0.00117	CcSEcCtD
Tiotropium—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00116	CcSEcCtD
Tiotropium—Rash—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00116	CcSEcCtD
Tiotropium—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00116	CcSEcCtD
Tiotropium—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00116	CcSEcCtD
Tiotropium—Headache—Formoterol—chronic obstructive pulmonary disease	0.000122	0.00115	CcSEcCtD
Tiotropium—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.00115	CcSEcCtD
Tiotropium—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.00115	CcSEcCtD
Tiotropium—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.00115	CcSEcCtD
Tiotropium—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00115	CcSEcCtD
Tiotropium—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00114	CcSEcCtD
Tiotropium—Rash—Montelukast—chronic obstructive pulmonary disease	0.00012	0.00113	CcSEcCtD
Tiotropium—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00012	0.00113	CcSEcCtD
Tiotropium—Headache—Montelukast—chronic obstructive pulmonary disease	0.000119	0.00113	CcSEcCtD
Tiotropium—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.00111	CcSEcCtD
Tiotropium—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000117	0.0011	CcSEcCtD
Tiotropium—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00109	CcSEcCtD
Tiotropium—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.00109	CcSEcCtD
Tiotropium—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00109	CcSEcCtD
Tiotropium—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.00109	CcSEcCtD
Tiotropium—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000116	0.00109	CcSEcCtD
Tiotropium—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.00109	CcSEcCtD
Tiotropium—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.00107	CcSEcCtD
Tiotropium—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000113	0.00107	CcSEcCtD
Tiotropium—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.00105	CcSEcCtD
Tiotropium—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00103	CcSEcCtD
Tiotropium—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000999	CcSEcCtD
Tiotropium—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000994	CcSEcCtD
Tiotropium—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.000978	CcSEcCtD
Tiotropium—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.00097	CcSEcCtD
Tiotropium—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00095	CcSEcCtD
Tiotropium—Angiopathy—Prednisone—chronic obstructive pulmonary disease	9.78e-05	0.000922	CcSEcCtD
Tiotropium—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	9.74e-05	0.000918	CcSEcCtD
Tiotropium—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	9.63e-05	0.000908	CcSEcCtD
Tiotropium—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.54e-05	0.000899	CcSEcCtD
Tiotropium—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.47e-05	0.000892	CcSEcCtD
Tiotropium—Mental disorder—Prednisone—chronic obstructive pulmonary disease	9.45e-05	0.000891	CcSEcCtD
Tiotropium—Malnutrition—Prednisone—chronic obstructive pulmonary disease	9.39e-05	0.000885	CcSEcCtD
Tiotropium—Vision blurred—Prednisone—chronic obstructive pulmonary disease	8.85e-05	0.000834	CcSEcCtD
Tiotropium—Angioedema—Prednisone—chronic obstructive pulmonary disease	8.58e-05	0.000809	CcSEcCtD
Tiotropium—Syncope—Prednisone—chronic obstructive pulmonary disease	8.42e-05	0.000794	CcSEcCtD
Tiotropium—Urticaria—Prednisolone—chronic obstructive pulmonary disease	8.38e-05	0.00079	CcSEcCtD
Tiotropium—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	8.25e-05	0.000778	CcSEcCtD
Tiotropium—Hypertension—Prednisone—chronic obstructive pulmonary disease	8.11e-05	0.000764	CcSEcCtD
Tiotropium—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.99e-05	0.000753	CcSEcCtD
Tiotropium—Myalgia—Prednisone—chronic obstructive pulmonary disease	7.99e-05	0.000753	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	7.94e-05	0.000748	CcSEcCtD
Tiotropium—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.77e-05	0.000732	CcSEcCtD
Tiotropium—Oedema—Prednisone—chronic obstructive pulmonary disease	7.66e-05	0.000722	CcSEcCtD
Tiotropium—Infection—Prednisone—chronic obstructive pulmonary disease	7.61e-05	0.000717	CcSEcCtD
Tiotropium—Shock—Prednisone—chronic obstructive pulmonary disease	7.54e-05	0.000711	CcSEcCtD
Tiotropium—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	7.51e-05	0.000708	CcSEcCtD
Tiotropium—Tachycardia—Prednisone—chronic obstructive pulmonary disease	7.48e-05	0.000705	CcSEcCtD
Tiotropium—Skin disorder—Prednisone—chronic obstructive pulmonary disease	7.44e-05	0.000701	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.98e-05	0.000658	CcSEcCtD
Tiotropium—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.97e-05	0.000657	CcSEcCtD
Tiotropium—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.93e-05	0.000653	CcSEcCtD
Tiotropium—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.88e-05	0.000648	CcSEcCtD
Tiotropium—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.74e-05	0.000636	CcSEcCtD
Tiotropium—Rash—Prednisolone—chronic obstructive pulmonary disease	6.65e-05	0.000627	CcSEcCtD
Tiotropium—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.64e-05	0.000626	CcSEcCtD
Tiotropium—Headache—Prednisolone—chronic obstructive pulmonary disease	6.61e-05	0.000623	CcSEcCtD
Tiotropium—Constipation—Prednisone—chronic obstructive pulmonary disease	6.55e-05	0.000618	CcSEcCtD
Tiotropium—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.27e-05	0.000591	CcSEcCtD
Tiotropium—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.26e-05	0.00059	CcSEcCtD
Tiotropium—Urticaria—Prednisone—chronic obstructive pulmonary disease	6.09e-05	0.000574	CcSEcCtD
Tiotropium—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	6.06e-05	0.000571	CcSEcCtD
Tiotropium—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.65e-05	0.000532	CcSEcCtD
Tiotropium—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.42e-05	0.000511	CcSEcCtD
Tiotropium—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.07e-05	0.000478	CcSEcCtD
Tiotropium—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.87e-05	0.000459	CcSEcCtD
Tiotropium—Rash—Prednisone—chronic obstructive pulmonary disease	4.83e-05	0.000455	CcSEcCtD
Tiotropium—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.83e-05	0.000455	CcSEcCtD
Tiotropium—Headache—Prednisone—chronic obstructive pulmonary disease	4.8e-05	0.000452	CcSEcCtD
Tiotropium—Nausea—Prednisone—chronic obstructive pulmonary disease	4.55e-05	0.000429	CcSEcCtD
Tiotropium—CHRM3—Metabolism—APIP—chronic obstructive pulmonary disease	2.52e-05	0.00203	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	2.51e-05	0.00203	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	2.45e-05	0.00198	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	2.44e-05	0.00197	CbGpPWpGaD
Tiotropium—CHRM1—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	2.4e-05	0.00194	CbGpPWpGaD
Tiotropium—SLC22A5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.39e-05	0.00193	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.32e-05	0.00188	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.31e-05	0.00187	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.31e-05	0.00186	CbGpPWpGaD
Tiotropium—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	2.3e-05	0.00186	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.3e-05	0.00186	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	2.29e-05	0.00185	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	2.28e-05	0.00184	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.26e-05	0.00183	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.24e-05	0.00181	CbGpPWpGaD
Tiotropium—CHRM1—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	2.24e-05	0.00181	CbGpPWpGaD
Tiotropium—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.15e-05	0.00173	CbGpPWpGaD
Tiotropium—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.12e-05	0.00171	CbGpPWpGaD
Tiotropium—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.12e-05	0.00171	CbGpPWpGaD
Tiotropium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.11e-05	0.00171	CbGpPWpGaD
Tiotropium—CHRM5—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	2.11e-05	0.0017	CbGpPWpGaD
Tiotropium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	2.09e-05	0.00169	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.07e-05	0.00168	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.07e-05	0.00167	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.05e-05	0.00166	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	2.05e-05	0.00165	CbGpPWpGaD
Tiotropium—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.02e-05	0.00164	CbGpPWpGaD
Tiotropium—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2e-05	0.00162	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.99e-05	0.0016	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.98e-05	0.0016	CbGpPWpGaD
Tiotropium—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.97e-05	0.00159	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.97e-05	0.00159	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.96e-05	0.00159	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	1.95e-05	0.00158	CbGpPWpGaD
Tiotropium—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.95e-05	0.00157	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	1.93e-05	0.00156	CbGpPWpGaD
Tiotropium—SLC22A4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.91e-05	0.00154	CbGpPWpGaD
Tiotropium—CHRM1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	1.89e-05	0.00152	CbGpPWpGaD
Tiotropium—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.87e-05	0.00151	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	1.85e-05	0.0015	CbGpPWpGaD
Tiotropium—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.84e-05	0.00149	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.81e-05	0.00147	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.81e-05	0.00146	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.79e-05	0.00145	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	1.79e-05	0.00145	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.79e-05	0.00144	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	1.77e-05	0.00143	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.77e-05	0.00143	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.76e-05	0.00142	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	1.74e-05	0.00141	CbGpPWpGaD
Tiotropium—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.68e-05	0.00136	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.67e-05	0.00135	CbGpPWpGaD
Tiotropium—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.66e-05	0.00134	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GC—chronic obstructive pulmonary disease	1.62e-05	0.00131	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.59e-05	0.00129	CbGpPWpGaD
Tiotropium—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.59e-05	0.00129	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.59e-05	0.00128	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.58e-05	0.00128	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.57e-05	0.00127	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	1.57e-05	0.00127	CbGpPWpGaD
Tiotropium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.57e-05	0.00127	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	1.57e-05	0.00127	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	1.56e-05	0.00126	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.51e-05	0.00122	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.5e-05	0.00122	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	1.5e-05	0.00122	CbGpPWpGaD
Tiotropium—CHRM1—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	1.48e-05	0.0012	CbGpPWpGaD
Tiotropium—CHRM3—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	1.48e-05	0.0012	CbGpPWpGaD
Tiotropium—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	1.46e-05	0.00118	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.45e-05	0.00117	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.44e-05	0.00116	CbGpPWpGaD
Tiotropium—SLC22A5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.43e-05	0.00116	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	1.43e-05	0.00115	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.42e-05	0.00115	CbGpPWpGaD
Tiotropium—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.4e-05	0.00113	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.4e-05	0.00113	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.39e-05	0.00113	CbGpPWpGaD
Tiotropium—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	1.39e-05	0.00112	CbGpPWpGaD
Tiotropium—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.38e-05	0.00112	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.38e-05	0.00112	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	1.38e-05	0.00112	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.38e-05	0.00111	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	1.36e-05	0.0011	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	1.34e-05	0.00109	CbGpPWpGaD
Tiotropium—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.29e-05	0.00104	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.29e-05	0.00104	CbGpPWpGaD
Tiotropium—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.27e-05	0.00103	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.27e-05	0.00102	CbGpPWpGaD
Tiotropium—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.22e-05	0.000988	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.21e-05	0.00098	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.21e-05	0.00098	CbGpPWpGaD
Tiotropium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.21e-05	0.000976	CbGpPWpGaD
Tiotropium—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.21e-05	0.000974	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.15e-05	0.00093	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.12e-05	0.000906	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.12e-05	0.000903	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.11e-05	0.000896	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.11e-05	0.000894	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.11e-05	0.000894	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	1.1e-05	0.000891	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.08e-05	0.000877	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.06e-05	0.000856	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.06e-05	0.000853	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.05e-05	0.000845	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.01e-05	0.000814	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	9.99e-06	0.000807	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.97e-06	0.000805	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	9.96e-06	0.000804	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	9.86e-06	0.000797	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	9.84e-06	0.000795	CbGpPWpGaD
Tiotropium—CHRM1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	9.8e-06	0.000792	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	9.69e-06	0.000783	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	9.07e-06	0.000733	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	9.04e-06	0.000731	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.01e-06	0.000728	CbGpPWpGaD
Tiotropium—CHRM1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	8.97e-06	0.000725	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	8.95e-06	0.000723	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	8.92e-06	0.000721	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	8.9e-06	0.000719	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	8.87e-06	0.000717	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.86e-06	0.000716	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	8.81e-06	0.000712	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GCLC—chronic obstructive pulmonary disease	8.76e-06	0.000707	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.54e-06	0.00069	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	8.54e-06	0.00069	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.51e-06	0.000688	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	8.51e-06	0.000688	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	8.5e-06	0.000687	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	8.48e-06	0.000685	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.43e-06	0.000681	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	8.43e-06	0.000681	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—KL—chronic obstructive pulmonary disease	8.25e-06	0.000666	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	8.1e-06	0.000655	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	8.08e-06	0.000653	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	8e-06	0.000647	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CTGF—chronic obstructive pulmonary disease	7.99e-06	0.000646	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	7.81e-06	0.000631	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	7.78e-06	0.000629	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	7.71e-06	0.000623	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.61e-06	0.000615	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.36e-06	0.000595	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.09e-06	0.000573	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7.07e-06	0.000571	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	7e-06	0.000566	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.85e-06	0.000554	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.8e-06	0.000549	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.52e-06	0.000527	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	6.34e-06	0.000512	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.24e-06	0.000505	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.22e-06	0.000503	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	6.22e-06	0.000503	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	6.18e-06	0.000499	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	6.16e-06	0.000498	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.14e-06	0.000496	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.05e-06	0.000489	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.95e-06	0.000481	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.89e-06	0.000476	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.81e-06	0.000469	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.79e-06	0.000468	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.73e-06	0.000463	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.64e-06	0.000456	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.53e-06	0.000447	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.36e-06	0.000433	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.35e-06	0.000432	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.34e-06	0.000432	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.3e-06	0.000428	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.29e-06	0.000427	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	5.23e-06	0.000423	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.82e-06	0.00039	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.81e-06	0.000389	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.79e-06	0.000387	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	4.78e-06	0.000386	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.77e-06	0.000386	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.76e-06	0.000385	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.73e-06	0.000382	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.55e-06	0.000367	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.4e-06	0.000356	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.38e-06	0.000354	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.37e-06	0.000353	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.35e-06	0.000352	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.34e-06	0.000351	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.34e-06	0.000351	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.32e-06	0.000349	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.3e-06	0.000347	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.19e-06	0.000338	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.18e-06	0.000337	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	4.14e-06	0.000335	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.13e-06	0.000334	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.89e-06	0.000315	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.88e-06	0.000314	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.84e-06	0.000311	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.67e-06	0.000297	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.67e-06	0.000297	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ALB—chronic obstructive pulmonary disease	3.64e-06	0.000294	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.62e-06	0.000293	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.49e-06	0.000282	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—NOS3—chronic obstructive pulmonary disease	3.48e-06	0.000281	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.46e-06	0.00028	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.42e-06	0.000277	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.37e-06	0.000273	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.32e-06	0.000269	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.2e-06	0.000259	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.2e-06	0.000258	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.19e-06	0.000258	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.16e-06	0.000255	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.12e-06	0.000252	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.06e-06	0.000247	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.05e-06	0.000246	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.02e-06	0.000244	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.98e-06	0.000241	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.92e-06	0.000236	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.91e-06	0.000235	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.88e-06	0.000233	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.88e-06	0.000233	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.74e-06	0.000221	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.69e-06	0.000217	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.59e-06	0.000209	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.58e-06	0.000208	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.55e-06	0.000206	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.46e-06	0.000199	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.45e-06	0.000198	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.43e-06	0.000196	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.4e-06	0.000194	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.37e-06	0.000191	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.34e-06	0.000189	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.33e-06	0.000189	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.31e-06	0.000187	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.26e-06	0.000182	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.21e-06	0.000178	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.17e-06	0.000176	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.1e-06	0.00017	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.09e-06	0.000169	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.09e-06	0.000169	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.08e-06	0.000168	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.07e-06	0.000168	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.06e-06	0.000167	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.93e-06	0.000156	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.92e-06	0.000155	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.9e-06	0.000154	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.89e-06	0.000153	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.89e-06	0.000152	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.87e-06	0.000151	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.59e-06	0.000128	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.58e-06	0.000128	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.57e-06	0.000127	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.45e-06	0.000117	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.45e-06	0.000117	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.43e-06	0.000116	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.42e-06	0.000115	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.36e-06	0.00011	CbGpPWpGaD
